Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
2,793,021
-
Shares change
-
+1,471,838
-
Total reported value, excl. options
-
$58,425,421
-
Value change
-
+$31,398,661
-
Number of buys
-
40
-
Number of sells
-
-4
-
Price
-
$20.92
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2016
48 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2016.
XBiotech Inc. - Common Shares, no par value (XBIT) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,793,021 shares
of 33,289,095 outstanding shares and own 8.39% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (871,482 shares), VANGUARD GROUP INC (502,618 shares), STATE STREET CORP (246,878 shares), NORTHERN TRUST CORP (191,127 shares), BlackRock Institutional Trust Company, N.A. (168,693 shares), BlackRock Investment Management, LLC (67,086 shares), GEODE CAPITAL MANAGEMENT, LLC (60,831 shares), Bank of New York Mellon Corp (58,049 shares), ING GROEP NV (53,611 shares), and GOLDMAN SACHS GROUP INC (52,248 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.